ArticleBreast cancer research and treatment2026

Dermatologic adverse events associated with Sacituzumab Govitecan: an international retrospective study from the EADV Task Force "Dermatology for Cancer Patients" and pharmacovigilance analysis.

Ioannis-Alexios Koumprentziotis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.